Amarin Corp Plcuk (AMRN) Other Non Operating Income (2010 - 2026)
Amarin Corp Plc\Uk (AMRN) posted quarterly Other Non Operating Income of $1.1 million for Q2 2026, up 1383.53% year-over-year from $73540.8 in Q2 2025, and up 480.32% quarter-over-quarter from $188000.0 in Q1 2026.
Amarin Corp Plcuk (AMRN) Other Non Operating Income (2010 - 2026) Analysis & Trends
Amarin Corp Plc\Uk (AMRN) has reported Other Non Operating Income for 17 consecutive years, with $1.1 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Other Non Operating Income rose 1383.53% year-over-year to $1.1 million; the TTM figure through Jun 2026 stood at $4.4 million (down 40.5% YoY), while the FY2025 annual figure was $3.3 million, down 63.17% from the prior year.
- Other Non Operating Income grew to $1.1 million in Q2 2026 per AMRN's latest filing, from $188000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $11.1 million in Q4 2022 and bottomed at -$2.3 million in Q2 2022.
- Historically, Other Non Operating Income has averaged $1.7 million across 5 years, with a median of $388000.0 in 2022.
- Annual changes were most pronounced in 2022 — Other Non Operating Income plunged 1080.63% — and 2026, when it surged 1383.53%.
- Amarin Corp Plc\Uk's Other Non Operating Income stood at $11.1 million in 2022, then sank by 55.53% to $5.0 million in 2023, then soared by 40.24% to $6.9 million in 2024, then tumbled by 58.17% to $2.9 million in 2025, then plunged by 62.43% to $1.1 million in 2026.
- Business Quant data shows AMRN's Other Non Operating Income at $1.1 million in Q2 2026, $188000.0 in Q1 2026, and $2.9 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Amarin Corp Plcuk | 5.86 Bn | 5.54 Bn | 14.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.09 Mn |
| Mar 31, 2026 | 188,000.00 |
| Dec 31, 2025 | 2.90 Mn |
| Sep 30, 2025 | 205,000.00 |
| Jun 30, 2025 | -85,000.00 |
| Mar 31, 2025 | 253,000.00 |
| Dec 31, 2024 | 6.94 Mn |
| Sep 30, 2024 | 265,000.00 |
| Jun 30, 2024 | 145,000.00 |
| Mar 31, 2024 | 1.55 Mn |
| Dec 31, 2023 | 4.95 Mn |
| Sep 30, 2023 | -575,000.00 |
| Jun 30, 2023 | 3.04 Mn |
| Mar 31, 2023 | 624,000.00 |
| Dec 31, 2022 | 11.13 Mn |
| Sep 30, 2022 | 511,000.00 |
| Jun 30, 2022 | -2.26 Mn |
| Mar 31, 2022 | -246,000.00 |
| Dec 31, 2021 | 5.64 Mn |
| Sep 30, 2021 | -57,000.00 |